首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Jingjing Li,Shujin Tang,Jiaoxing Li et al. Jingjing Li et al.
leukoencephalopathy, congenital myotonia, congenital myasthenic syndrome, Dravet syndrome, Fabry disease, hereditary spastic paraplegia, Huntington disease, Leber hereditary optic neuropathy, mitochondrial encephalopathy (ME), multi-focal motor neuropathy, myotonic dystrophy, primary hereditary dystonia, progressive...muscular dystrophy (PMD), spinal and bulbar muscular atrophy, spinal muscular atrophy (SMA), spinocerebellar ataxia, Wilson disease (WD) and X-linked adrenoleukodystrophy.
A B González Escobar,I E Molina Guilabert,R M García Herrera et al. A B González Escobar et al.
Facioscapulohumeral muscular dystrophy (FSHMD) is a slowly progressive muscular dystrophy that affects especially the muscles of the face, shoulder girdle and upper arms. It may present extramuscular manifestations such as hearing loss and retinopathy.
Sergey N Bardakov,Roman V Deev,Vadim A Tsargush et al. Sergey N Bardakov et al.
Dysferlinopathy is a phenotypically heterogeneous, inherited, progressive muscular dystrophy caused by mutations in the DYSF gene. Dysferlinopathy is marked by elevated serum creatine kinase (CK) and can in some cases manifest as hyperCKemia in asymptomatic or low-symptom states.
Pritam Daniel Sundaresan,Michael Williams Pritam Daniel Sundaresan
The patient had a diagnosis of progressive muscular dystrophy and mobilised in a motorised wheelchair. He was dependent for dressing and bathing, but independent for grooming. He had no cognitive impairment and provided his own consent.
Takahiro Fujimoto,Miyuki Mori,Madoka Tonosaki et al. Takahiro Fujimoto et al.
Duchenne/Becker muscular dystrophy (DMD/BMD) manifests progressive muscular dystrophy and non-progressive central nervous disorder. The neural disorder is possibly caused by abnormalities in the developmental period; however, basic research to understand the mechanisms remains underdeveloped.
Solene Sohn,Sophie Reid,Maximilien Bowen et al. Solene Sohn et al.
Our results confirm the progressive muscular dystrophy previously described but also highlight biases associated with tamoxifen injections and the complexity of choosing the genes used to calculate a DUX4-pathway gene composite score.
Tessa Arends,Danielle C Hamm,Silvère van der Maarel et al. Tessa Arends et al.
DUX4 expression in these skeletal muscles reactivates part of the early totipotent program and suppresses the muscle program-resulting in a progressive muscular dystrophy that affects some muscles earlier than others.
Susan E Matesanz,Jonathan B Edelson,Katherine A Iacobellis et al. Susan E Matesanz et al.
Male patients 1-18 years with an ICD-9/10 diagnosis code for hereditary progressive muscular dystrophy between January 1, 2013, and December 31, 2017, were included. Participants were stratified into 3 age cohorts: 1-6 years, 7-12 years, and 13-18 years.
Hao Hu,Xiao-Wen Yang,De-Hua Cheng et al. Hao Hu et al.
Duchenne/Becker muscular dystrophy (DMD/BMD) is one of the most common progressive muscular dystrophy diseases with X-linked recessive inheritance. It is mainly caused by the deletion, duplication and point mutation of DMD gene.
耗时 0.15136 秒,为您在 48229835 条记录里面共找到 1212 篇文章 [XML]